Related Experiment Video
Updated: Aug 24, 2026

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
Prostein expression is highly restricted to normal and malignant prostate tissues
Michael Kalos1, Jon Askaa, Bonnie L Hylander
1Corixa Corporation, Seattle, Washington 98104, USA.
Background:
Prostein is a recently described molecule expressed at the mRNA level in a prostate-specific manner. A murine monoclonal antibody was developed, characterized, and used to evaluate the expression of prostein protein in prostatic, other normal tissue and tumor samples.
Methods:
The murine anti-prostein monoclonal antibody 10E3-G4-D3 was generated using recombinant prostein. ELISA, FACS, and Western analyzes were used to characterize 10E3-G4-D3. Immunohistochemistry was used to characterize the expression of prostein in tissues.
Results:
10E3-G4-D3 specifically recognizes a linear intracellular epitope of prostein. IHC analysis demonstrates that prostein is expressed in the vast majority of normal and malignant prostatic tissues, regardless of grade and metastatic status. No protein expression is detected in a panel of approximately 4,700 normal and malignant tissue samples representing the great majority of essential tissues and tumors.
Conclusions:
Prostein is exquisitely specific for prostate tissues, indicating a potential clinical utility of 10E3-G4-D3 as a diagnostic biomarker, and support the use of prostein as a novel target for development of prostein-specific antibody and T-cell based therapeutic strategies for prostate cancer.
Insights
Prostein protein is highly specific to prostate tissues. A new antibody, 10E3-G4-D3, confirms prostein
Area of Science:
- Biochemistry
- Immunology
- Oncology
Background:
- Prostein is a prostate-specific molecule identified at the mRNA level.
- A murine monoclonal antibody (10E3-G4-D3) was developed to detect prostein protein.
- The antibody's expression was evaluated in various normal and tumor tissues.
Purpose of the Study:
- To characterize the anti-prostein monoclonal antibody 10E3-G4-D3.
- To determine the protein expression pattern of prostein in normal and malignant tissues.
- To assess the potential of prostein as a diagnostic biomarker and therapeutic target for prostate cancer.
Main Methods:
- Generation of a murine anti-prostein monoclonal antibody (10E3-G4-D3) using recombinant prostein.
- Characterization of the antibody using ELISA, FACS, and Western blot analyses.
- Immunohistochemistry (IHC) was employed to analyze prostein expression in tissue samples.
Main Results:
- The 10E3-G4-D3 antibody specifically recognizes a linear intracellular epitope of prostein.
- Prostein protein is expressed in most normal and malignant prostatic tissues, irrespective of grade or metastatic status.
- No prostein protein expression was detected in approximately 4,700 samples from other normal and malignant tissues.
Conclusions:
- Prostein exhibits exceptional specificity for prostate tissues.
- The 10E3-G4-D3 antibody shows potential as a diagnostic biomarker for prostate cancer.
- Prostein is a promising novel target for developing prostein-specific antibody and T-cell based therapies for prostate cancer.
Related Concept Videos
Abnormal Proliferation
Reporter Genes
Commonly used reporter...

